0
Humalog™ (Insulin Lispro Injection USP) is a rapid-acting insulin analog used to manage blood sugar levels in individuals with diabetes mellitus. Designed for subcutaneous injection, it begins working within 15 minutes of administration, making it ideal for mealtime glucose control. Each box contains 5 prefilled insulin pens, offering convenience, precision, and portability for individuals managing diabetes.
Key Features:
- Rapid-Acting Formula: Onset of action as quick as 15 minutes, peak effect within 1–2 hours, and duration up to 4–6 hours.
- Accurate Dosing: Prefilled pens allow for precise dosing adjustments in 1-unit increments up to 60 units per injection.
- User-Friendly Design: Ergonomic prefilled pens ensure ease of use, even for individuals with limited dexterity.
- Convenient Storage: Pens are portable and require no refrigeration after initial use (must be kept below 86°F and used within 28 days).
Indications:
- Type 1 Diabetes Mellitus: For use in patients requiring mealtime insulin to manage blood sugar levels.
- Type 2 Diabetes Mellitus: For patients who need rapid glucose control alongside long-acting insulin or oral antidiabetic medications.
Specifications:
- Product Code: ELI-300027516592
- Concentration: 100 units/mL (U-100)
- Presentation: Prefilled insulin pens (5 pens per box, each containing 3mL of solution).
- Active Ingredient: Insulin lispro (recombinant DNA origin).
- Injection Method: Subcutaneous or via continuous infusion pump systems.
Benefits for Patients and Providers:
- Flexibility: Rapid onset allows for administration as close as 15 minutes before meals or even immediately after eating.
- Portability: Compact pens fit easily into daily routines, enabling discreet and on-the-go administration.
- Reduced Waste: Prefilled pens minimize wastage compared to vials and syringes.
- Enhanced Compliance: Easy-to-use design promotes adherence to prescribed insulin regimens.
